Purdue Institute for Drug Discovery

IM-3050

Overview: 

FAP-targeted radiotherapy for the treatment of solid tumors

Status: 

Purdue Faculty: 

Dr. Phil Low

Clinical Trial Information: 

Phase 1 Trial

Development Partner: 

Immunome